Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene Therapy for Mucopolysaccharidosis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapy for Mucopolysaccharidosismarket, defines the market attractiveness level of Gene Therapy for Mucopolysaccharidosis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy for Mucopolysaccharidosis industry, describes the types of Gene Therapy for Mucopolysaccharidosis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy for Mucopolysaccharidosis market and the development prospects and opportunities of Gene Therapy for Mucopolysaccharidosis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy for Mucopolysaccharidosis market in Chapter 13.
By Player:
uniQure
Swedish Orphan Biovitrum
Sangamo Therapeutics
By Type:
Intravenous
ICV
Intracerebral
Intracisternal
By End-User:
Mucopolysaccharidosis I
Mucopolysaccharidosis II
Mucopolysaccharidosis III A
Mucopolysaccharidosis III B
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy for Mucopolysaccharidosis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy for Mucopolysaccharidosis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy for Mucopolysaccharidosis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy for Mucopolysaccharidosis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy for Mucopolysaccharidosis Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy for Mucopolysaccharidosis Consumption (2017-2022)
-
7.2 United States Gene Therapy for Mucopolysaccharidosis Consumption (2017-2022)
-
7.3 Europe Gene Therapy for Mucopolysaccharidosis Consumption (2017-2022)
-
7.4 China Gene Therapy for Mucopolysaccharidosis Consumption (2017-2022)
-
7.5 Japan Gene Therapy for Mucopolysaccharidosis Consumption (2017-2022)
-
7.6 India Gene Therapy for Mucopolysaccharidosis Consumption (2017-2022)
-
7.7 South Korea Gene Therapy for Mucopolysaccharidosis Consumption (2017-2022)
8 Region and Country-wise Gene Therapy for Mucopolysaccharidosis Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy for Mucopolysaccharidosis Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy for Mucopolysaccharidosis Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy for Mucopolysaccharidosis Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy for Mucopolysaccharidosis Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy for Mucopolysaccharidosis Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy for Mucopolysaccharidosis Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy for Mucopolysaccharidosis Consumption Forecast (2022-2028)
9 Global Gene Therapy for Mucopolysaccharidosis Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ICV Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Intracerebral Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Intracisternal Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Mucopolysaccharidosis I Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Mucopolysaccharidosis III A Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Mucopolysaccharidosis III B Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy for Mucopolysaccharidosis Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global ICV Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Intracerebral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Intracisternal Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Mucopolysaccharidosis I Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Mucopolysaccharidosis III A Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Mucopolysaccharidosis III B Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy for Mucopolysaccharidosis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy for Mucopolysaccharidosis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy for Mucopolysaccharidosis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy for Mucopolysaccharidosis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy for Mucopolysaccharidosis Market Competitive Analysis
-
14.1 uniQure
-
14.1.1 uniQure Company Details
-
14.1.2 uniQure Gene Therapy for Mucopolysaccharidosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 uniQure Gene Therapy for Mucopolysaccharidosis Product and Service
-
14.2 Swedish Orphan Biovitrum
-
14.2.1 Swedish Orphan Biovitrum Company Details
-
14.2.2 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Product and Service
-
14.3 Sangamo Therapeutics
-
14.3.1 Sangamo Therapeutics Company Details
-
14.3.2 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy for Mucopolysaccharidosis
-
Figure Gene Therapy for Mucopolysaccharidosis Picture
-
Table Global Gene Therapy for Mucopolysaccharidosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy for Mucopolysaccharidosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy for Mucopolysaccharidosis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy for Mucopolysaccharidosis Consumption by Country (2017-2022)
-
Figure United States Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy for Mucopolysaccharidosis Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy for Mucopolysaccharidosis Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy for Mucopolysaccharidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Consumption and Growth Rate (2017-2022)
-
Figure Global ICV Consumption and Growth Rate (2017-2022)
-
Figure Global Intracerebral Consumption and Growth Rate (2017-2022)
-
Figure Global Intracisternal Consumption and Growth Rate (2017-2022)
-
Figure Global Mucopolysaccharidosis I Consumption and Growth Rate (2017-2022)
-
Figure Global Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)
-
Figure Global Mucopolysaccharidosis III A Consumption and Growth Rate (2017-2022)
-
Figure Global Mucopolysaccharidosis III B Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ICV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intracerebral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intracisternal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mucopolysaccharidosis I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mucopolysaccharidosis III A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mucopolysaccharidosis III B Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy for Mucopolysaccharidosis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy for Mucopolysaccharidosis Export by Region (Top 5 Countries) (2017-2028)
-
Table uniQure (Foundation Year, Company Profile and etc.)
-
Table uniQure Gene Therapy for Mucopolysaccharidosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table uniQure Gene Therapy for Mucopolysaccharidosis Product and Service
-
Table Swedish Orphan Biovitrum (Foundation Year, Company Profile and etc.)
-
Table Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Product and Service
-
Table Sangamo Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Product and Service
-
